[go: up one dir, main page]

NO972304L - Vitamin D3-analoger - Google Patents

Vitamin D3-analoger

Info

Publication number
NO972304L
NO972304L NO972304A NO972304A NO972304L NO 972304 L NO972304 L NO 972304L NO 972304 A NO972304 A NO 972304A NO 972304 A NO972304 A NO 972304A NO 972304 L NO972304 L NO 972304L
Authority
NO
Norway
Prior art keywords
chj
hydroxy
hydrogen
analogues
vitamin
Prior art date
Application number
NO972304A
Other languages
English (en)
Other versions
NO972304D0 (no
Inventor
Andrew David Batcho
Graeme Findlay Bryce
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972304D0 publication Critical patent/NO972304D0/no
Publication of NO972304L publication Critical patent/NO972304L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forbindelser med formel HO hvor R er hydrogen, fluor eller hydroksy, Rj er hydrogen, lavere alkyl eller halogen, X er =CH2, eller når R er hydroksy, er X (H,H) eller =CH2, og A cr -C=C- \ / c=c c=c / \ eller -CHj-CHj-, er nyttige ved behandling av hyperproli- ferative hudforstyrrelser, neoplaBtiske sykdommer, sebaceuse kjertelsykdommer og tilstander forbundet med hud skadet av sollys .
NO972304A 1996-05-23 1997-05-21 Vitamin D3-analoger NO972304L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1815396P 1996-05-23 1996-05-23
US1818696P 1996-05-23 1996-05-23
US3990097P 1997-03-19 1997-03-19

Publications (2)

Publication Number Publication Date
NO972304D0 NO972304D0 (no) 1997-05-21
NO972304L true NO972304L (no) 1997-11-24

Family

ID=27360973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972304A NO972304L (no) 1996-05-23 1997-05-21 Vitamin D3-analoger

Country Status (29)

Country Link
EP (2) EP1464640A3 (no)
JP (1) JP2859247B2 (no)
KR (1) KR100783856B1 (no)
CN (1) CN1176072C (no)
AR (1) AR007241A1 (no)
AT (1) ATE277008T1 (no)
AU (1) AU723929B2 (no)
BR (1) BR9703384A (no)
CA (1) CA2205275C (no)
CO (1) CO4950531A1 (no)
CZ (1) CZ157897A3 (no)
DE (1) DE69730774T2 (no)
DK (1) DK0808833T3 (no)
ES (1) ES2227635T3 (no)
HR (1) HRP970273A2 (no)
HU (1) HUP9700926A3 (no)
IL (1) IL120843A0 (no)
MA (1) MA24251A1 (no)
NO (1) NO972304L (no)
NZ (1) NZ314839A (no)
PE (1) PE70198A1 (no)
PL (1) PL320132A1 (no)
PT (1) PT808833E (no)
SG (1) SG70009A1 (no)
TR (1) TR199700415A2 (no)
TW (1) TW445252B (no)
UY (1) UY24561A1 (no)
YU (1) YU20197A (no)
ZA (1) ZA974336B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
JP2002515898A (ja) * 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
JP2002506429A (ja) * 1997-05-16 2002-02-26 ウィメン アンド インファンツ ホスピタル ３−エピビタミンｄ２化合物及びその使用法
JP2002505668A (ja) 1997-05-16 2002-02-19 ウィメン アンド インファンツ ホスピタル 環状エーテルビタミンＤ３化合物、１α（ＯＨ）３−エピ−ビタミンＤ３化合物及びそれらの使用法
EP0957098A1 (en) * 1998-05-14 1999-11-17 F. Hoffmann-La Roche Ag Intermediates for the synthesis of 3-epi vitamin D3 metabolites and analogs
US6603030B1 (en) 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
SI3146969T1 (en) * 1999-04-23 2018-08-31 Leo Pharma A/S Ointment for topical treatment of psoriasis
US6255501B1 (en) 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
US20020045606A1 (en) * 1999-12-02 2002-04-18 Reddy Satyanarayana G. Esters of vitamin D3 and uses thereof
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
US7332482B2 (en) 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
BRPI0404050A (pt) * 2003-09-24 2005-06-14 Bioxell Spa Uso de um composto ou de um seu sal ou éster farmaceuticamente aceitável, formulação farmacêutica, formulação acondicionada, composto, e, método para prevenir e/ou tratar hiperplasia benigna da próstata em pacientes em necessidade de tal prevenção ou tratamento
AU2005216651A1 (en) 2004-03-01 2005-09-09 Bioxell Spa Treatment of interstitial cystitis with vitamin D compounds
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
US8906888B2 (en) * 2005-04-25 2014-12-09 Cytochroma Inc. Low-calcemic 16,23-diene 25-oxime analogs of 1α,25-dihydroxy vitamin D3
CN101287705A (zh) * 2005-08-18 2008-10-15 拜奥艾克塞尔股份公司 1α-氟-25-羟基-16-23E-二烯-26,27-双高-20-表-胆骨化醇的合成
CA2676512A1 (en) * 2007-01-25 2008-07-31 Bioxell S.P.A. Synthesis of 1.alpha.-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
CA2688083C (en) 2007-05-30 2015-07-07 Cytochroma Inc. Process for producing phosphine oxide vitamin d precursors
ES2366077B2 (es) * 2010-03-30 2012-06-25 Universidade De Vigo Compuestos quirales, procedimientos de obtención y uso.
BR112013009647A2 (pt) * 2010-10-25 2016-07-12 Teijin Pharma Ltd derivado de vitamina, composição farmacêutica, agente terapêutico, e, composto
KR101812860B1 (ko) * 2012-11-07 2017-12-27 브이아이디 스케일, 인크. Ｈｄｒ 비디오를 디노이징하기 위한 시간적 필터
CN105348164B (zh) * 2015-10-29 2017-03-29 无锡福祈制药有限公司 一种1α‑羟基维生素D2的制备方法
CN106748942B (zh) * 2016-11-28 2018-06-29 无锡福祈制药有限公司 度骨化醇类似物wxfq-65及其合成方法
ES2731558B2 (es) * 2018-05-15 2020-03-18 Univ Santiago Compostela Compuestos de interés farmacéutico
CN109738252B (zh) * 2019-01-23 2021-03-09 深圳天辰医疗科技有限公司 25-羟基-维生素d解离液
CN109696435B (zh) * 2019-01-25 2021-03-09 深圳天辰医疗科技有限公司 维生素d的测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP3228488B2 (ja) * 1993-12-24 2001-11-12 株式会社クラレ ２０−エピステロイド誘導体およびその製造方法

Also Published As

Publication number Publication date
ES2227635T3 (es) 2005-04-01
PE70198A1 (es) 1998-11-26
PT808833E (pt) 2004-11-30
MA24251A1 (fr) 1998-04-01
NO972304D0 (no) 1997-05-21
DK0808833T3 (da) 2005-01-31
CO4950531A1 (es) 2000-09-01
EP1464640A3 (en) 2005-01-12
CN1175573A (zh) 1998-03-11
AR007241A1 (es) 1999-10-27
ATE277008T1 (de) 2004-10-15
DE69730774D1 (de) 2004-10-28
TW445252B (en) 2001-07-11
AU723929B2 (en) 2000-09-07
MX9703774A (es) 1998-06-30
CZ157897A3 (en) 1997-12-17
EP1464640A2 (en) 2004-10-06
IL120843A0 (en) 1997-09-30
UY24561A1 (es) 2000-12-29
EP0808833A2 (en) 1997-11-26
JP2859247B2 (ja) 1999-02-17
TR199700415A3 (tr) 1997-12-21
EP0808833A3 (en) 1998-11-25
NZ314839A (en) 2000-01-28
EP0808833B1 (en) 2004-09-22
TR199700415A2 (xx) 1997-12-21
JPH1045713A (ja) 1998-02-17
HU9700926D0 (en) 1997-07-28
HRP970273A2 (en) 1998-04-30
CA2205275A1 (en) 1997-11-23
ZA974336B (en) 1997-11-24
YU20197A (sh) 1999-09-27
KR100783856B1 (ko) 2008-05-09
HUP9700926A3 (en) 1999-05-28
CN1176072C (zh) 2004-11-17
BR9703384A (pt) 1998-09-15
KR970074765A (ko) 1997-12-10
PL320132A1 (en) 1997-11-24
DE69730774T2 (de) 2005-09-29
AU2357797A (en) 1997-11-27
SG70009A1 (en) 2000-01-25
HUP9700926A2 (hu) 1998-01-28
CA2205275C (en) 2007-04-03

Similar Documents

Publication Publication Date Title
NO972304L (no) Vitamin D3-analoger
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
DE69229944D1 (de) Verwendung von N-Acylaminoalkoholen zur Herstellung eines Arzneimittels zur Behandlung von Mastzellerkrankungen
ATE141914T1 (de) Fluorierte analoge vitamins d3
TW374762B (en) Fluorinated vitamin D3 analogs
ATE119887T1 (de) Benzimidazolderivate, ihre herstellung und ihre verwendung.
GR3002618T3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
DE59001281D1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
NO934197L (no) Vitamin D-3-analoger
ATE1625T1 (de) Isoxazolylcarbonsaeureanilide, ihre herstellung, diese enthaltende fungizide mittel und verfahren zur bekaempfung von pilzen.
AU5516590A (en) Dehydrocholecalciferol derivatives
ATE488T1 (de) Halogenierte 1-azolyl-1-f luorphenoxy-butan-derivate, verfahren zu ihrer herstellung, sie enthaltende fungizide mittel sowie ihre verwendung als fungizide.
DK0399358T3 (da) Butensyrederivater
ATE10361T1 (de) Derivate von 3-phenoxy-2-propanolen, ihre herstellung und ihre therapeutische verwendung.
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung
GR81056B (en) Method for the preparation of indanyl-derivatives and use thereof
EP0796843A3 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
ATE17485T1 (de) 3,7a-diazacyclohepta(j,k)fluorenderivate, ihre herstellung und ihre therapeutische verwendung.
ATE18039T1 (de) 2,3,5,6-tetrasubstituierte p-benzochinone, ihre herstellung und verwendung.
DK0687661T3 (da) Phenylindaner, fremgangsmåde til fremstilling samt anvendelse
ECSP972129A (es) Analogos de vitamina d3
DE3785232D1 (de) Analoge der methylthioribose, ihre herstellung sowie medizinische und biozide verwendung.
ATE78466T1 (de) 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung.
JPS55164833A (en) Sensitizer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application